Transcription factor abnormalities in B-ALL leukemogenesis and treatment

H Yin, J Wang, Y Tan, M Jiang, H Zhang, G Meng - Trends in Cancer, 2023 - cell.com
The biological regulation of transcription factors (TFs) and repressor proteins is an important
mechanism for maintaining cell homeostasis. In B cell acute lymphoblastic leukemia (B-ALL) …

Dithiocarbazate ligands and their Ni (II) complexes with potential biological activity: Structural, antitumor and molecular docking study

CQO Cavalcante, THA da Mota… - Frontiers in Molecular …, 2023 - frontiersin.org
In the search for new metal complexes with antitumor potential, two dithiocarbazate ligands
derived from 1, 1, 1-trifluoro-2, 4-pentanedione (H2L1) and (H2L2) and four Ni (II) …

Super‐Enhancer‐Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T‐ALL Cell Growth and Survival

J Yu, Z Zhang, Y Chen, J Wang, G Li, Y Tao… - Advanced …, 2025 - Wiley Online Library
Super enhancers (SEs) are large clusters of transcriptional enhancers driving the
expression of genes crucial for defining cell identity. In cancer, tumor‐specific SEs activate …

A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia

H Zhang, G Meng - Blood Science, 2022 - mednexus.org
B-cell acute lymphoblastic leukemia (B-ALL) is a malignant tumor originating from B-lineage
lymphoid precursor cells. The incidence of B-ALL is about 80% in childhood acute leukemia …

Integrative alternative splicing analysis reveals new prognosis signature in B-cell acute lymphoblastic leukemia

Z Zhuo, J Wang, Y Zhang… - International Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
The dysregulation of alternative splicing (AS) is increasingly recognized as a pivotal player
in the pathogenesis, progression, and treatment resistance of B-cell acute lymphoblastic …

Transcription factor 12‐mediated self‐feedback regulatory mechanism is required in DUX4 fusion leukaemia

Z Li, M Jiang, J Wang, Z Zhuo, S Zhang… - Clinical and …, 2023 - Wiley Online Library
Background IGH:: DUX4 is frequently observed in 4% B‐cell acute lymphoblastic leukaemia
patients. Regarding the IGH:: DUX4‐driven transactivation and alternative splicing, which …

[Retracted] Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia

Y Liu, H Nuriding, L Zhao, X Wang… - … Methods in Medicine, 2022 - Wiley Online Library
Objective. This study investigated the types and significance of mutant genes in children with
acute lymphoblastic leukemia (ALL). Methods. The gene sequencing data of 89 ALL …

Targeting DUX4-r leukemia via PI3K and CD371

Z Li, G Meng - Blood, 2024 - ashpublications.org
In this issue of Blood, Thorsson et al report a comprehensive single-cell multiomics analysis
of 23 childhood B-cell progenitor acute lymphoblastic leukemia (BCP-ALL) cases, identifying …

RAG1: THE CORNERSTONE GENE INVOLVED IN VARIOUS IMMUNE DISEASES AND CANCERS

MM Fawzy, MH Nazmy, M Fathy - Bulletin of Pharmaceutical …, 2023 - bpsa.journals.ekb.eg
RAG1 is an abbreviation for recombination activating gene-1 which is the cornerstone in the
process of V (D) J recombination. The process enables our immune system to produce an …

[PDF][PDF] Research Article Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia

Y Liu, H Nuriding, L Zhao, X Wang, Y Yue, Y Song… - 2022 - scienceopen.com
Objective. This study investigated the types and significance of mutant genes in children with
acute lymphoblastic leukemia (ALL). Methods. The gene sequencing data of 89 ALL …